Mind Medicine Inc. (($MNMD)) announced an update on their ongoing clinical study. Study Overview: Mind Medicine Inc. is conducting a Phase 3 trial ...

Xenon Pharmaceuticals (($XENE)) announced an update on their ongoing clinical study. Study Overview: Xenon Pharmaceuticals is conducting a Phase 3 ...

A new study suggests nitrous oxide may offer a new treatment option for older adults with treatment-resistant depression.

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

Fecal transplants are intended to restore our digestive tract with a healthy ecosystem of microbes, which can become degraded ...

A comprehensive meta-analysis in depression and mortality, led by the Department of Psychiatry at the School of Clinical ...

Front-line health care workers struggling with depression after the COVID-19 pandemic experienced significant relief from a ...

One man living with major depressive disorder shares how working with his psychiatrist led him to understand his treatment-emergent sexual dysfunction.

In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Najaf Amin unveils transformative insights ...

Depression may affect a person’s likelihood of achieving optimal recovery after cancer surgery, according to retrospective ...

Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression ...

Different types of depression affect the body in different ways. Atypical, energy-related depression raises the risk of ...